These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2975205)

  • 1. Soluble CD23/BLAST-2 (S-CD23/Blast-2) and its role in B cell proliferation.
    Swendeman SL; Thorley-Lawson D
    Curr Top Microbiol Immunol; 1988; 141():157-64. PubMed ID: 2975205
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of CD23 antigen is not necessary for human 12-kDa B cell growth factor-mediated B cell proliferation.
    Vazquez A; Mills S; Sharma S; Maizel AL
    Eur J Immunol; 1988 Oct; 18(10):1647-9. PubMed ID: 2973416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a CD23 counterstructure other than IgE.
    Gordon J
    Res Immunol; 1992 May; 143(4):428-31. PubMed ID: 1387717
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
    Luo HY; Hofstetter H; Banchereau J; Delespesse G
    J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth.
    Guy GR; Gordon J
    Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6239-43. PubMed ID: 2957693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intact, 45-kDa (membrane) form of CD23 is consistently mitogenic for normal and transformed B lymphoblasts.
    Cairns JA; Gordon J
    Eur J Immunol; 1990 Mar; 20(3):539-43. PubMed ID: 2138559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia.
    Sarfati M; Fournier S; Christoffersen M; Biron G
    Leuk Res; 1990; 14(1):47-55. PubMed ID: 2137545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
    Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
    J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional implication for the topographical relationship between MHC class II and the low-affinity IgE receptor: occupancy of CD23 prevents B lymphocytes from stimulating allogeneic mixed lymphocyte responses.
    Flores-Romo L; Johnson GD; Ghaderi AA; Stanworth DR; Veronesi A; Gordon J
    Eur J Immunol; 1990 Nov; 20(11):2465-9. PubMed ID: 2147649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors.
    Bujanowski-Weber J; Brings B; Knöller I; Pfeil T; König W
    Immunology; 1989 Apr; 66(4):505-11. PubMed ID: 2523859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The low-affinity receptor for IgE (CD23) on B lymphocytes is spatially associated with HLA-DR antigens.
    Bonnefoy JY; Guillot O; Spits H; Blanchard D; Ishizaka K; Banchereau J
    J Exp Med; 1988 Jan; 167(1):57-72. PubMed ID: 2961843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4.
    Dugas B; Paul-Eugene N; Cairns J; Gordon J; Calenda A; Mencia-Huerta JM; Braquet P
    J Immunol; 1990 Nov; 145(10):3406-11. PubMed ID: 2172383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional interaction between B cell subpopulations defined by CD23 expression.
    Armitage RJ; Goff LK
    Eur J Immunol; 1988 Nov; 18(11):1753-60. PubMed ID: 2974422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgE.
    Saxon A; Ke Z; Bahati L; Stevens RH
    J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):333-44. PubMed ID: 1698844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble forms of CD40 inhibit biologic responses of human B cells.
    Fanslow WC; Anderson DM; Grabstein KH; Clark EA; Cosman D; Armitage RJ
    J Immunol; 1992 Jul; 149(2):655-60. PubMed ID: 1378075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of biologically active human recombinant 37 kDa soluble CD23 (sFc epsilon RII) expressed in insect cells.
    Graber P; Jansen K; Pochon S; Shields J; Aubonney N; Turcatti G; Bonnefoy JY
    J Immunol Methods; 1992 May; 149(2):215-26. PubMed ID: 1534340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation by interleukin 2 of CD23 expression of leukemic and normal B cells: comparison with interleukin 4.
    Hivroz C; Vallé A; Brouet JC; Banchereau J; Grillot-Courvalin C
    Eur J Immunol; 1989 Jun; 19(6):1025-30. PubMed ID: 2526738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affinity-purified soluble Fc epsilon RII/CD23 derived from RPMI-8866 cells induces histamine release from human nasal polyp mast cells through a non-IgE-mediated mechanism.
    Ghaderi AA; Jones VM; Stanworth DR
    Immunol Lett; 1991 Feb; 27(2):113-8. PubMed ID: 1709143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phenotypic study of cells from Burkitt lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues.
    Ling NR; Hardie D; Lowe J; Johnson GD; Khan M; MacLennan IC
    Int J Cancer; 1989 Jan; 43(1):112-8. PubMed ID: 2536003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease.
    Furukawa S; Matsubara T; Motohashi T; Sasai K; Nakachi S; Umezawa Y; Yabuta K
    Int Arch Allergy Appl Immunol; 1991; 95(1):7-12. PubMed ID: 1833342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.